New SEC Document(s) for Achillion Pharmaceuticals

SEC Filing Alert Achillion Pharmaceuticals has filed the following document(s) with the United States Securities and Exchange Commission. Apr 06, 2011 Form Pre 14A / Preliminary Proxy Statement HTML PDF View all SEC Filings

You are subscribed to Achillion Pharmaceuticals Investor Relations' e-mail alerts as clotito+biotechdash@gmail.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. Achillion Pharmaceuticals 300 George St. , New Haven, CT 06511 Service provided by Shareholder.com